Melissa B (Epperly, Director) sold ~$172K of Roivant Sciences
Scheduled in advanceLoading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director exercised or converted 105K ROIV derivative securities
Traded Aug 18, 2026 · Filed Aug 19, 2026
- 105K
- Shares · @ $3.85
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 18, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 19, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-033637